Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Annals of Hematology
Published in: Annals of Hematology 6/2014

01-06-2014 | Letter to the Editor

Pulmonary lymphocyte-rich classical Hodgkin lymphoma with early response to ABVD therapy

Authors: Akira Honda, Fumihiko Nakamura, Yasuhito Nannya, Yukako Shintani, Masashi Fukayama, Motoshi Ichikawa, Mineo Kurokawa

Published in: Annals of Hematology | Issue 6/2014

Login to get access

Excerpt

Dear Editor, …
Literature
1.
2.
Yousem SA, Weiss LM, Colby TV (1986) Primary pulmonary Hodgkin’s disease. A clinicopathologic study of 15 cases. Cancer 57(6):1217–1224PubMedCrossRef
3.
Canellos GP, Anderson JR, Propert KJ, Nissen N, Cooper MR, Henderson ES, Green MR, Gottlieb A, Peterson BA (1992) Chemotherapy of advanced Hodgkin’s disease with MOPP, ABVD, or MOPP alternating with ABVD. N Engl J Med 327(21):1478–1484PubMedCrossRef
4.
Meyer RM, Gospodarowicz MK, Connors JM, Pearcey RG, Wells WA, Winter JN, Horning SJ, Dar AR, Shustik C, Stewart DA, Crump M, Djurfeldt MS, Chen BE, Shepherd LE, Group NCT, Group ECO (2012) ABVD alone versus radiation-based therapy in limited-stage Hodgkin’s lymphoma. N Engl J Med 366(5):399–408PubMedCentralPubMedCrossRef
Metadata
Title
Pulmonary lymphocyte-rich classical Hodgkin lymphoma with early response to ABVD therapy
Authors
Akira Honda
Fumihiko Nakamura
Yasuhito Nannya
Yukako Shintani
Masashi Fukayama
Motoshi Ichikawa
Mineo Kurokawa
Publication date
01-06-2014
Publisher
Springer Berlin Heidelberg
Published in
Annals of Hematology / Issue 6/2014
Print ISSN: 0939-5555
Electronic ISSN: 1432-0584
DOI
https://doi.org/10.1007/s00277-013-1935-6

Other articles of this Issue 6/2014

Annals of Hematology 6/2014 Go to the issue

Original Article

Normal karyotype acute myeloid leukemia with the CD7+ CD15+ CD34+ HLA-DR + immunophenotype is a clinically distinct entity with a favorable outcome

Erratum

Erratum to: A 30-year epidemiologic survey (1974–2003) of haematological malignancies on the island of Sardinia: temporal changes in incidence and a geographic comparison of incidence rates

Original Article

Predictors of plasma cell disorders among African American patients: a community practice perspective

Original Article

The G8 screening tool detects relevant geriatric impairments and predicts survival in elderly patients with a haematological malignancy

Letter to the Editor

MiR-125b regulates cell proliferation and survival in neonatal megakaryocytes

Letter to the Editor

Mast cell sarcoma mimicking metastatic colon carcinoma

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits